Status:
COMPLETED
NAFLD in Diabetes Type 2 in Primary Care
Lead Sponsor:
Linkoeping University
Conditions:
NAFLD
Eligibility:
All Genders
35-75 years
Brief Summary
The EPSONIP (Evaluating Prevalence and Severity Of NAFLD In Primary care) trial is a longitudinal cohort study of patients with T2DM recruited from primary health care centers in Östergötland, Sweden....
Eligibility Criteria
Inclusion
- Diabetes type 2
- Age 35-75 year
Exclusion
- Contraindication to MR
- Alcohol dependance
- Previously diagnosed liver cirrhosis
- Previously known liver disease (other than fatty liver)
Key Trial Info
Start Date :
April 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
317 Patients enrolled
Trial Details
Trial ID
NCT03864510
Start Date
April 1 2019
End Date
December 1 2023
Last Update
December 12 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Ekholmen primary health care centre
Linköping, Swedish, Sweden, 58185
2
Åby primary health care centre
Norrköping, Sweden